Automated lung sound analysis using the ChestPal Pro (previously known as LungPass) platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19
Lower respiratory tract (LRT) involvement, observed in about 20% of patients suffering from coronavirus disease 2019 (COVID-19), is associated with a more severe clinical course, adverse outcomes, and long-term sequelae [1, 2]. By pointing out people at risk of deterioration, early identification of LRT involvement could facilitate targeted and timely administration of treatments that could alter…